Neutrophil gelatinase-associated lipocalin as a marker of postoperative acute kidney injury following cardiac surgery in patients with preoperative kidney impairment

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 19, Issue 3, 2019, Pages 239-248

  Tidbury, N ^a   Browning, N ^a   Shaw, M ^a   Morgan, M ^a   Kemp, I ^a   Matata, B ^a,b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Acute kidney injury; Cardiac surgery; ELISA; Lipocalin; NGAL; Renal impairment

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; LCN2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHEST INFECTION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSPOT ASSAY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HEART SURGERY; HEMOFILTRATION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MILD RENAL IMPAIRMENT; OFF PUMP SURGERY; POST HOC ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PULMONARY VALVE REPLACEMENT; RECEIVER OPERATING CHARACTERISTIC; REOPERATION; SENSITIVITY AND SPECIFICITY; URINE SAMPLING; URINE VOLUME; ADVERSE EVENT; AGED; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; URINE; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; KIDNEY; LIPOCALIN-2; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 85074963968     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X19666190415115106     Document Type: Article

References (42)

1. Uchino, S.; Kellum, J.A.; Bellomo, R.; Doig, G.S.;, Morimatsu, H.; Morgera, S.; Schetz, M.; Tan, I.; Bouman, C.; Macedo, E.; Gibney, N.; Tolwani, A.; Ronco, C.; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: A multinational, multicenter study. J. Am. Med.Assoc., 2005, 294(7), 813-818.
2. Mao, H.; Katz, N.; Ariyanon, W.; Blanca-Martos, L.; Adýbelli, Z.; Giuliani, A.; Danesi, T.H.; Kim, J.C.; Nayak, A.; Neri, M.; Virzi, G.M.; Brocca, A.; Scalzotto, E.; Salvador, L.; Ronco, C. Cardiac surgery-associated acute kidney injury. CardioRenal. Med., 2013, 3(3), 178-199.
3. Hansen, M.K.; Gammelager, H.; Mikkelsen, M.M.; Hjortdal, V.E.; Layton, J.B.; Johnsen, S.P.; Christiansen, C.F. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: A cohort study. Crit. Care, 2013, 17(6), R292.
4. Rosner, M.H.; Okusa, M.D. Acute kidney injury associated with cardiac surgery. Clin. J. Am. Soc. Nephrol., 2006, 1(1), 19-32.
5. Thiele, R.H.; Isbell, J.M.; Rosner, M.H. AKI associated with cardiac surgery. Clin. J. Am. Soc. Nephrol., 2015, 10, 500-514.
6. Kiers, H.D.; van den Boogaard, M.; Schoenmakers, M.C.J.; van der Hoeven, J.G.; van Swieten, H.A.; Heemskerk, S.; Pickkers, P. Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol. Dial. Transplant., 2013, 28, 345-351.
7. Garg, A.X.; Shehata, N.; McGuinness, S.; Whitlock, R; Fergusson, D.; Wald, R.; Parikh, C.;, Bagshaw, S.M.; Khanykin, B.; Gregory, A.; Syed, S.; Hare, G.M.T.; Cuerden, M.S.; Thorpe, K.E.; Hall, J.; Verma, S.; Roshanov, P.S.; Sontrop, J.M.; Mazer, C.D. (2018) Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: A sub study protocol of the transfusion requirements in cardiac surgery III noninferiority trial. Can. J. Kidney Health Dis., 2018, 5, 2054358117749532.
8. Dasta, J.F.; Kane-Gill, S.L.; Durtschi, A.J.; Pathak, D.S.; Kellum, J.A. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol. Dial.Transplant., 2008, 23, 1970-1974.
9. Chertow, G.M.; Burdick, E.; Honour, M.; Bonventre, J.V.; Bates, D. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol., 2005, 16, 3365-3370.
10. Ishani, A.; Nelson, D.; Clothier, B.; Schult, T.; Nugent, S.; Greer, N.; Slinin, Y.; Ensrud, K.E. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch. Intern. Med., 2011, 171, 226-233.
11. Machado, M.N; Nakazone, M.A.; Maia, L.N. Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery. Rev. Bras. Cir. Cardiovasc., 2014, 29(3), 299-307.
12. Nickolas, T.L.; Forster, C.S.; Sise, M.E.; Barasch, N.; Valle, D.S.; Viltard, M.; Buchen, C.; Kupferman, S.; Carnevali, M.L.; Bennett, M.; Mattei, S.; Bovino, A.; Argentiero, L.; Magnano, A.; Devarajan, P.; Mori, K.; Erdjument-Bromage, H.; Tempst, P.; Allegri, L.; Barasch, J. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int., 2012, 82(6), 718-722.
13. Han, M.; Li, Y.; Liu, M.; Li, Y.; Cong, B. Renal neutrophil gelatinase associated lipocal in expression in lipopolysaccharide induced acute kidney injury in the rat. BMC Nephrol., 2012, 13(1), 25.
14. Dent, C.L.; Ma, Q.; Dastrala, S.; Bennett, M.; Mitsnefes, M.M.;, Barasch, J.; Devarajan, P. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit. Care, 2007, 11(6), R:127.
15. Mishra, J.; Dent, C.; Tarabishi, R.; Mitsnefes, M.M.; Ma, Q.; Kelly, C.; Ruff, S.M.; Zahedi, K.; Shao, M.; Bean, J.; Mori, K.; Barasch, J. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet, 2005, 365(9466), 1231-1238.
16. Friedrich, M.G.; Bougioukas, I.; Kolle, J.; Bireta, C.; Jebran, F.A.; Placzek, M.; Tirilomis, T.N. GAL expression during cardiopulmonary bypass does not predict severity of postoperative acute kidney injury. BMC Nephrol., 2017, 18(1), 1-7.
17. Koyner, J.L.; Bennett, M.R.; Worcester, E.M.; Ma, Q.; Raman, J.; Jeevanandam, V.; Kasza, K.E.; O’Connor, M.F.; Konczal, D.J.; Trevino, S.; Devarajan, P.; Murray, P.T.I Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int., 74(8), 2008, 1059-1069.
18. Wagener, G.; Jan, M.; Kim, M.; Mori, K.; Barasch, J.M.; Sladen, R.N.; Lee, HT. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology, 2006, 105(3), 485-491.
19. Wagener, G.; Gubitosa, G.; Wang, S.; Borregaard, N.; Kim, M.; Lee, H.T. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am. J. Kidney Dis., 2008, 52(3), 425-433.
20. McMahon, G.M.; Waikar, S.S. Biomarkers in nephrology: Core Curriculum 2013. Am. J. Kidney Dis., 2013, 62, 165-178.
21. Devarajan, P. Neutrophil gelatinase-associated lipocalin: Apromising biomarker for human acute kidney injury. Biomark. Med., 2010, 4, 265-280.
22. Matata, B.M.; Scawn, N.; Morgan, M.; Shirley, S.; Kemp, I.; Richards, S.; Lane, S.; Wilson, K.; Stables, R.; Jackson, M.; Haycox, A.; Mediratta, N. A single-center randomized trial of intraoperative zero-balanced ultrafiltration during cardiopulmonary bypass for patients with impaired kidney function undergoing cardiac surgery. J. Cardiothorac. Vasc. Anesth., 2015, 29(5), 1236-1247.
23. KDIGO Clinical Practice Guideline for Acute Kidney Injury Kidney International Supplements 2012. 2:1. doi:10.1038/kisup.2012.1. http://www.kidney-international.org.
24. Wright, G. Hemolysis during cardiopulmonary bypass: Update. Perfusion, 2001, 16, 345-351.
25. Baliga, R.; Ueda, N.; Waler, P.D.; Shah, S.V. Oxidant mechanisms in toxic acute renal failure. Am. J. Kidney Dis., 1997, 29, 465-477.
26. Davis, C.L.; Kausz, A.T.; Zager, R.A.; Kharasch, E.D.; Cochran, R.P. Acute renal failure after cardiopulmonary bypass is related to decreased serum ferritin levels. J. Am. Soc. Nephrol., 1999, 10, 2396-2402.
27. Messmer, K. Hemodilution. Surg. Clin. North Am., 1975, 55, 659-678.
28. Shah, D.; Corson, J.; Karmody, A.; Leather, R. Effects of isovolemichemodilution on abdominal aortic aneurysmectomy in high risk patients. Ann. Vasc. Surg., 1986, 1, 50-54.
29. Swaminathan, M.; Phillips-Bute, B.G.; Conlon, P.J.; Smith, P.K.; Newman, M.F.; Stafford-Smith, M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann. Thorac. Surg., 2003, 76, 784-792.
30. Karkouti, K.; Beattie, W.S.; Wijeysundera, D.N.; Rao, V.; Chan, C.; Dattilo, K.M.; Djaiani, G.; Ivanov, J.; Karski, J.; David, T.E. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J. Thorac. Cardiovasc. Surg., 2005, 129, 391-400.
31. Kjeldsen, L.; Johnsen, A.H.; Sengelov, H.; Borregaard, N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem., 1993, 268(14), 10425-10432.
32. Schmidt-Ott, K.M.; Mori, K.; Jau, Y.L.; Kalandadze, A.; Cohen, D.J.; Devarajan, P.; Barasch, J. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc.Nephrol., 2007, 18(2), 407-413.
33. Goetz, D.H.; Holmes, M.A.; Borregaard, N.; Bluhm, M.E.; Raymond, K.N.; Strong, R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell., 2002, 10(5), 1033-1043.
34. Mishra, J.; Qing, M.A.; Prada, A.; Mitsnefes, M.; Zahedi, K.; Yang, J.; Barasch, J.; Devarajan, P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol., 2003, 14(10), 2534-2543.
35. Mori, K.; Lee, H.T.; Rapoport, D.; Drexler, I.R.; Foster, K.; Yang, J.; Schmidt-Ott, K.M.; Chen, X.; Li, J.Y.; Weiss, S.; Mishra, J.; Cheema, F.H.; Markowitz, G.; Suganami, T.; Sawai, K.; Mukoyama, M.; Kunis, C.; D’Agati, V.; Devarajan, P.; Barasch, J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest., 2005, 115(3), 610-621.
36. Hemdahl, A.;, Gabrielsen, A.; Zhu, C.; Eriksson, P.; Hedin, U.; Kastrup, J.; Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 2006, 26(1), 136-142.
37. Eilenberg, W.; Stojkovic, S.; Piechota-Polanczyk, A.; Kaun, C.; Rauscher, S.; Gröger, M.; Klinger, M.; Wojta, J.; Neumayer, C.; Huk, I.; Demyanets, S. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur. J. Vasc. Endovasc. Surg., 2016, 51(5), 623-631.
38. Kashani, K.; Al-Khafaji, A.; Ardiles, T.; Artigas, A.; Bagshaw, S.M.; Bell, M.; Bihorac, A.; Birkhahn, R.; Cely, C.M.; Chawla, L.S.; Davison, D.L.; Feldkamp, T.; Forni, L.G.; Gong, M.N.; Gunnerson, K.J.; Haase, M.; Hackett, J.; Honore, P.M.; Hoste, E.A.; Joannes-Boyau, O.; Joannidis, M.; Kim, P.; Koyner, J.L.; Laskowitz, D.T.; Lissauer, M.E.; Marx, G.; McCullough, P.A.; Mullaney, S.; Ostermann, M.; Rimmelé, T.; Shapiro, N.I.; Shaw, A.D.; Shi, J.; Sprague, A.M.; Vincent, J.L.; Vinsonneau, C.; Wagner, L.; Walker, M.G.; Wilkerson, R.G.; Zacharowski, K.; Kellum, J.A. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care., 2013, 17, R25.
39. McCullough, P.A.; Shaw, A.D.; Haase, M.; Bouchard, J.; Waikar, S.S.; Siew, E.D.; Murray, P.T.; Mehta, R.L.; Ronco, C. Diagnosis of acute kidney injury using functional and injury biomarkers: Workgroup statements from the tenth acute dialysis quality initiative consensus conference. Contrib. Nephrol., 2013, 182, 13-29.
40. Boonstra, J.; Post, J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene., 2004, 337, 1-13.
41. Seo, D.W.; Li, H.; Qu, C.K.; Oh, J.; Kim, Y.S.; Diaz, T.; Wei, B.; Han, J.W.; Stetler-Stevenson, W.G. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J. Biol. Chem., 2006, 281, 3711-3721.
42. Price, P.N.; Safirstein, R.L.; Megyesi, J. The cell cycle and acute kidney injury. Kidney Int., 2009, 76, 604-613.